DE111® Approved as Non-Novel Food by Health Canada
Deerland Enzymes & Probiotics has announced that its proprietary strain of Bacillus subtilis DE111 has been granted non-Novel Food ingredient status in Canada. A letter of non-objection has been received from Health Canada, confirming that DE111 is not considered a Novel Food and may be sold as a food ingredient.
About Deerland Enzymes
Deerland Enzymes & Probiotics, based in Kennesaw, Ga., specializes in customized enzyme and probiotic-based formulations, collaborating with customers to develop innovative and often proprietary solutions. In addition to customized formulations, the company offers a line of university and clinically studied branded products. Deerland provides regulatory support and also performs specialty contract manufacturing services, including bulk blends, liquids, hard shell capsules, and tablets; as well as bottling and labeling. To contact Deerland Enzymes & Probiotics, call 800.697.8179 or email info@DeerlandEnzymes.com.